ZBIOZenas BioPharma, Inc.

ZBIO Stock Price, Valuation & Chart | Zenas BioPharma, Inc.

Compare

$33.130+1.15 (+3.60%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology ZBIO intrinsic value ZBIO calculated fair value vs price

Overview Financials Dividends Ratios

ZBIO Historical price chart

ZBIO Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.09B

PE Ratio-3.69

EPS-8.99

Trading Volume757.48K

Today's High/Low33.45/31.93

Dividend Yield0.00

52 Week High/Low44.6/13.5

Shares Outstanding63.13M

ZBIO Financial Statement

ZBIO Analyst ratings

ZBIO Analysis & performance metrics

ZBIO Company profile

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead…

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic…

ZBIO Management team

Name

Position

Jennifer A. FoxCFO

Chief Business Officer & Chief Financial Officer

Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Caroline Chevalier

Chief Human Resources Officer

Haley Laken Ph.D.

Chief Scientific Officer

Orlando Oliveira

Chief Commercial Officer

Jeffrey Held

Chief Legal Officer

Leon Oliver Moulder Jr., M.B.A.CEO

Chief Executive Officer & Chairman of the Board

Joseph L. FarmerCOO

Chief Operating Officer & President

Name

Position

Jennifer A. FoxCFO

Chief Business Officer & Chief Financial Officer

Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Caroline Chevalier

Chief Human Resources Officer

Haley Laken Ph.D.

Chief Scientific Officer

Orlando Oliveira

Chief Commercial Officer

Jeffrey Held

Chief Legal Officer

Leon Oliver Moulder Jr., M.B.A.CEO

Chief Executive Officer & Chairman of the Board

Joseph L. FarmerCOO

Chief Operating Officer & President

Management Team

Jennifer A. FoxCFO

Chief Business Officer & Chief Financial Officer

Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Caroline Chevalier

Chief Human Resources Officer

Haley Laken Ph.D.

Chief Scientific Officer

Orlando Oliveira

Chief Commercial Officer

Jeffrey Held

Chief Legal Officer

Leon Oliver Moulder Jr., M.B.A.CEO

Chief Executive Officer & Chairman of the Board

Joseph L. FarmerCOO

Chief Operating Officer & President

Management

Jennifer A. FoxCFO

Chief Business Officer & Chief Financial Officer

Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Caroline Chevalier

Chief Human Resources Officer

Haley Laken Ph.D.

Chief Scientific Officer

Orlando Oliveira

Chief Commercial Officer

Jeffrey Held

Chief Legal Officer

Leon Oliver Moulder Jr., M.B.A.CEO

Chief Executive Officer & Chairman of the Board

Joseph L. FarmerCOO

Chief Operating Officer & President

Total 8 executives

ZBIO Frequently asked questions

What is Zenas BioPharma, Inc. (ZBIO) Stock Price?

Current stock price of Zenas BioPharma, Inc. (ZBIO) stock is $33.130. The stock price is +3.60% higher in the session. The intraday range can be seen from this page. Volume of Zenas BioPharma, Inc. (ZBIO) stock is 757.48K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Zenas BioPharma, Inc. (ZBIO) stock price going up or down today?

The stock price of Zenas BioPharma, Inc. (ZBIO) can change with earnings, company news, and overall market sentiment. Zenas BioPharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Zenas BioPharma, Inc. stock expensive at its current price?

Whether Zenas BioPharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ZBIO on this page is -3.69. EPS on this page is -8.99. Compare those figures with peers and growth expectations before deciding if the current Zenas BioPharma, Inc. price is justified.

How has the stock price of Zenas BioPharma, Inc. (ZBIO) performed historically?

Historical performance for Zenas BioPharma, Inc. (ZBIO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ZBIO reacted to past earnings and market events.

Should I buy Zenas BioPharma, Inc. (ZBIO) stock, at this price?

Buying Zenas BioPharma, Inc. (ZBIO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.